Sign In

Adam Knight, PhD

Neuroscience VC | Founder @Neuron23 | Advisor @Soda Health

Professional Background

Adam Knight, PhD, is a distinguished scientist and business leader with over a decade of experience in biomedical research. His career has been marked by significant contributions to the understanding and treatment of neurodegenerative diseases, particularly Parkinson's disease. As Co-founder and Partner at Neuro.VC, he has been instrumental in promoting innovation in the life sciences sector. Additionally, Adam has held advisory positions at reputable organizations including Soda Health and Perceptive Advisors, wherein he shared his expertise in genetics and molecular biology to advise on technological advancements and investment opportunities.

His venture into executive leadership as the Founder and Chief Executive Officer of Neuron23 Inc. showcases his dedication to translating scientific discoveries into tangible therapies for patients. During his tenure, he successfully guided the company’s mission to address unmet medical needs in neuroscience and beyond.

Adam's experience extends to investment banking at IMS Health Capital where he utilized his scientific acumen to add value to strategic investments in healthcare. His work in management consulting at IQVIA and translational research at Miltenyi Biotec further solidified his business intelligence in the life sciences arena, allowing him to effectively bridge the gap between science and business.

Education and Achievements

Dr. Knight's educational background lays a strong foundation for his expertise in the field. He earned his PhD in Neuroscience and Genetics from the esteemed University of Cambridge, a program known for its rigorous training and pioneering research contributions. Additionally, he holds both a Master of Science (MS) and a Bachelor of Science (BS) in Genetics from The University of Alabama, where he fostered his interest in genetics and its potential to revolutionize patient care.

Throughout his career, Adam has authored two textbook chapters and 11 scientific articles published in top-tier journals, highlighting his commitment to advancing knowledge within the scientific community. His research has not only contributed to the body of knowledge in genetics and neurodegenerative diseases but has also identified potential therapeutics aimed at addressing critical health challenges faced by aging populations.

Achievements

Dr. Adam Knight’s notable achievements reflect his leadership and dedication to science and its applications. He has excelled in multiple roles that require both scientific expertise and business acumen, particularly in the fields of genetics, molecular biology, immuno-oncology, aging, diabetes, and gene therapy. His reputation as a thought leader is enhanced by his active participation in various scientific advisory boards, including his role at Locust Walk, which has been pivotal in mentoring early-stage companies in the biopharmaceutical sector.

Through his journey as a scientist and entrepreneur, Adam has remained focused on one key objective: bringing innovative therapies to patients. His combination of rigorous academic training, extensive research experience, and comprehensive business knowledge uniquely positions him to influence future developments in healthcare. Adam’s work exemplifies a commitment not only to scientific advancement but to the ethical and responsible translation of research into practical therapies that enhance patient outcomes.

Related Questions

How did Adam Knight develop his expertise in neurodegenerative diseases?
What are some of the notable findings from Adam Knight's research on Parkinson's disease?
In what ways has Adam Knight's background in science influenced his roles in venture capital and consulting?
What inspired Adam Knight to bridge his scientific knowledge with business strategy in the life sciences sector?
How does Adam Knight approach the challenge of translating scientific discoveries into innovative therapies for patients?
Adam Knight, PhD
Add to my network

Location

San Francisco Bay Area